Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bridgewater, John"'
Autor:
Taylor, Stuart A, Mallett, Susan, Miles, Anne, Morris, Stephen, Quinn, Laura, Clarke, Caroline S, Beare, Sandy, Bridgewater, John, Goh, Vicky, Janes, Sam, Koh, Dow-Mu, Morton, Alison, Navani, Neal, Oliver, Alfred, Padhani, Anwar, Punwani, Shonit, Rockall, Andrea, Halligan, Steve
Publikováno v:
Health Technology Assessment, Vol 23, Iss 66 (2019)
Background Whole-body magnetic resonance imaging is advocated as an alternative to standard pathways for staging cancer. Objectives The objectives were to compare diagnostic accuracy, efficiency, patient acceptability, observer variability and cost-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd341bb5ff98d7e4b4d9440cf5b27339
http://hdl.handle.net/10044/1/77695
http://hdl.handle.net/10044/1/77695
Autor:
Iveson T; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Boyd KA; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Kerr RS; Department of Oncology, University of Oxford, Oxford, UK., Robles-Zurita J; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Saunders MP; The Christie Hospital NHS Foundation Trust, Manchester, UK., Briggs AH; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Cassidy J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hollander NH; Department of Oncology and Palliative Care, Zealand University Hospital, Naestved, Denmark., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Haydon A; Australasian Gastro-Intestinal Trials Group, Camperdown, NSW, Australia., Glimelius B; University of Uppsala, Uppsala, Sweden., Harkin A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Allan K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McQueen J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Pearson S; Oncology Clinical Trials Office, Department of Oncology, University of Oxford, Oxford, UK., Waterston A; Beatson West of Scotland Cancer Centre, Glasgow, UK., Medley L; Royal United Hospital, Bath, UK., Wilson C; Addenbrooke's Hospital, Cambridge, UK., Ellis R; Royal Cornwall Hospitals NHS Trust, Cornwall, UK., Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., Dhadda AS; Castle Hill Hospital, Hull, UK., Harrison M; Mount Vernon Cancer Centre, Northwood, UK., Falk S; Bristol Cancer Institute, Bristol, UK., Raouf S; Barking Havering and Redbridge University Hospital NHS Trust, Barking, UK., Rees C; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Olesen RK; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Propper D; Barts Cancer Institute, Queen Mary University of London, London, UK., Bridgewater J; Department of Oncology, University College London, London, UK., Azzabi A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Farrugia D; Gloucestershire Oncology Centre, Cheltenham General Hospital, UK., Webb A; Brighton and Sussex University Hospital Trust, Brighton, UK., Cunningham D; Royal Marsden NHS Foundation Trust, London, UK., Hickish T; Poole Hospital NHS Foundation Trust, Poole, UK., Weaver A; Department of Oncology, Oxford University Hospitals Foundation Trust, Oxford, UK., Gollins S; North Wales Cancer Treatment Centre, Rhyl, UK., Wasan H; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Paul J; The Christie Hospital NHS Foundation Trust, Manchester, UK.
Publikováno v:
Health technology assessment (Winchester, England) [Health Technol Assess] 2019 Dec; Vol. 23 (64), pp. 1-88.